Patent details

EP2461870 Title: COMPOSITION COMPRISING BETA-GLUCAN AND AN EGF-R ANTIBODY OR AN EGF-R ANTAGONIST FOR USE IN THE TREATMENT OF KRAS-MUTATED TUMORS

Basic Information

Publication number:
EP2461870
PCT Application Number:
US2010042925
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP108029125
PCT Publication Number:
WO2011011617
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITION COMPRISING BETA-GLUCAN AND AN EGF-R ANTIBODY OR AN EGF-R ANTAGONIST FOR USE IN THE TREATMENT OF KRAS-MUTATED TUMORS
French Title of Invention:
COMPOSITION COMPRENANT BETA-GLUCANE ET UN ANTICORPS ANTI-EGFR OU UN INHIBITEUR DE L'EGFR DANS LE TRAITEMENT DES TUMEURS AVEC MUTATION KRAS
German Title of Invention:
ZUSAMMENTSETZUNG ENTHALTEND BETA-GLUCAN UND EIN EGF-R-ANTIKÖRPER ODER EIN EGF-R INHIBITOR ZUR VERWENDUNG IN DER BEHANDLUNG VON KRAS-MUTIERTEN TUMOREN
SPC Number:

Dates

Filing date:
22/07/2010
Grant date:
06/09/2017
EP Publication Date:
13/06/2012
PCT Publication Date:
27/01/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2017
EP B1 Publication Date:
06/09/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/07/2018
Expiration date:
22/07/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/09/2017
 
 

Name:
Biothera, Inc.
Address:
3388 Mike Collins Drive, Eagan, MN 55121, United States (US)

Inventor

Name:
VASILAKOS, John, P.
Address:
United States (US)

Priority

Priority Number:
271514 P
Priority Date:
22/07/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/716; A61K 39/395; A61K 45/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201736
Publication date:
06/09/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2018 Outgoing Correspondence 1